Palifermin

In the US, Palifermin (palifermin systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Mucositis.

US matches:

• Palifermin


• Palifermin Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

V03AF08

CAS registry number (Chemical Abstracts Service)

0162394-19-6

Chemical Formula

C724-H1147-N203-O206-S9

Molecular Weight

16279

Therapeutic Categories

Growth factor

Fibrinoblast Growth Factor, human

Chemical Names

24-163 fibroblast growht factor 7 (human) (USAN)

human fibroblast growth factor-(24-163)-peptide (WHO)

Peptide-(24-163)-facteur de croissance du fibroblaste humain

Peptido-(24-163)-factor de crecimiento del fibroblasto humano

Foreign Names

• Paliferminum (Latin)
• Palifermin (German)
• Palifermine (French)
• Palifermina (Spanish)

Generic Names

• Palifermin (OS: USAN)
• Keratinocyte Growth Factor (IS: Amgen)
• KGF (IS)
• rh KGF (IS)
• rHu-KGf (IS)

Brand Names

• Kepivance
  Amgen, United Arab Emirates; Amgen, Austria; Amgen, Belgium; Amgen, Bahrain; Amgen, Czech Republic; Amgen, Germany; Amgen, Egypt; Amgen, Spain; Amgen, Finland; Amgen, Hungary; Amgen, Ireland; Amgen, Iraq; Amgen, Iran; Amgen, Italy; Amgen, Jordan; Amgen, Kuwait; Amgen, Lebanon; Amgen, Luxembourg; Amgen, Norway; Amgen, Oman; Amgen, Poland; Amgen, Qatar; Amgen, Saudi Arabia; Amgen, Syria; Amgen, United States; Amgen, Yemen; Amgen Switzerland, Switzerland; Biovintrum, Greece; Biovitrum, France; Biovitrum, United Kingdom; Biovitrum, Sweden; Biovitrum AB, Netherlands; PharmaLink, Australia; Amgen Europe B.VNL, Denmark

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.